CVS Health Corporation

NYSE:CVS

Medical - Healthcare Plans

Healthcare
$81.35 -0.59%

-$0.59 today

Market cap
$104.08B
Beta
0.62
P/E (TTM)
42.8
EPS (TTM)
$2.30
Dividend yield
2.70%
52W Low $58.50High $102.77

Volume 17.19M

Average 8.19M

CVS Accounts Receivables

Cash effect of the change in amounts owed by customers; growing receivables consume cash.

CVS Health CorporationNYSE: CVS

Accounts Receivables · Q2 FY2026 · quarter ended Jun 2026

Accounts receivables turns positive

Q2 FY2026 accounts receivables was $1.88B, compared with -$1.09B a year earlier. Trailing-twelve-month accounts receivables was $1.31B. Over 3 fiscal years it compounded at +5.6% a year.

Context

  • Accounts receivables amounted to 0.9% of revenue in FY2025, up 0.5 pp from a year earlier.
  • Accounts receivables grew in size in 2 of the last 3 fiscal years.

What to watch

Whether quarterly accounts receivables holds near $1.88B or moves back toward the trailing-twelve-month quarterly average of $328.25M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJun 2026
$1.88B+255.8% QoQ
Last fiscal yearDec 2025
-$3.5B+168.9% YoY
LTMJun 2026
$1.31B+115.9% YoY
Accounts Receivables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+272.8%——
1 year+168.9%——
3-year CAGR+5.6%——
5-year CAGR——
10-year CAGR——

Accounts Receivables history

USD · from the cash flow

Latest · FY2025
(3.5B) USD
Year-over-year change
-168.9%

Accounts Receivables vs competitors

How CVS compares with its peers on the latest reported figures

  • CVS's LTM Jun 2026 accounts receivables of $1.31B is the 2nd largest of the 9 companies compared; the peer median is $102.5M.
  • Its year-over-year change of +115.9% is the 3rd highest of 9, against a peer median of -71.3%.
  • Accounts receivables amounts to 0.3% of revenue for CVS, versus a peer median of 0.4%.
CVS Competitors Peer median
Accounts Receivables for CVS and competitors
Company Period LTM YoY 3-year CAGR% of revenue
CNCCentene CorporationLTM Jun 2026$1.54B -69.6%—0.8%
CVSCVS Health CorporationLTM Jun 2026$1.31B +115.9%+5.6%0.3%
CICigna CorporationLTM Sep 2026$489M -87.2%+27.4%0.2%
MOHMolina Healthcare, Inc.LTM Sep 2026$373M +326.1%+15.1%0.9%
HUMHumana Inc.LTM Sep 2026$147M -73.0%+119.4%0.1%
ELVElevance Health Inc.LTM Sep 2026$140M -96.0%+0.2%0.1%
OSCROscar Health, Inc.LTM Jun 2026$81.93M +512.9%—0.5%
UNHUnitedHealth Group IncorporatedLTM Sep 2026$65M -96.8%—0.0%
ALHCAlignment Healthcare, Inc.LTM Mar 2026$30.77M -37.4%+42.8%0.7%
Peer median (excluding CVS) $102.5M-71.3%+27.4%0.4%

Competitors are the stored peer set for CVS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income7.99B4.33B8.37B4.59B1.73B
Depreciation & Amortization4.49B4.22B4.37B4.6B4.61B
Deferred Income Tax(402M)(2.03B)(676M)(572M)102M
Stock-Based Compensation484M447M588M540M535M
Change in Working Capital3.86B6.82B15M109M(1.47B)
Accounts Receivables(2.7B)(2.97B)(6.26B)(1.3B)(3.5B)
Inventory735M(1.44B)1.23B(102M)(1.27B)
Accounts Payables2.9B4.26B3.62B2.34B3.86B
Other Working Capital2.93B6.96B1.42B(823M)(564M)
Other Non-Cash Items1.85B2.39B765M(153M)5.14B
Operating Cash Flow18.27B16.18B13.43B9.11B10.64B
Capital Expenditures(2.52B)(2.73B)(3.03B)(2.78B)(2.83B)
Acquisitions (Net)(146M)(1.39B)(16.61B)(95M)(436M)
Purchases of Investments(9.96B)(7.75B)(9.04B)(15.19B)(15.01B)
Sales of Investments7.25B6.73B7.73B10.35B12.38B
Other Investing Activities122M85M68M101M26M
Investing Cash Flow(5.26B)(5.05B)(20.89B)(7.61B)(5.87B)
Debt Repayment(9.27B)(4.21B)7.93B5.06B(3.9B)
Common Stock Issued0000394M
Common Stock Repurchased0(3.5B)(2.01B)(3.02B)0
Dividends Paid(2.63B)(2.91B)(3.13B)(3.37B)(3.4B)
Other Financing Activities536M102M(105M)202M1.96B
Financing Cash Flow(11.36B)(10.52B)2.68B(1.14B)(4.94B)
Effect of Forex Changes00000
Net Change in Cash1.65B614M(4.78B)359M(172M)
Free Cash Flow15.75B13.45B10.4B6.33B7.81B

CVS Health Corporation

NYSE:CVS

Intrinsic Alpha fair value

Locked

Current Price

$81.35

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.